Month: March 2022

AgEagle Subsidiary, senseFly, Selected as a Blue UAS Approved Drone SupplierMilitary serviceman preparing to launch senseFly’s eBee TAC in active flight demo Military serviceman preparing to launch senseFly’s eBee TAC in active flight demoWICHITA, Kan. and LAUSANNE, Switzerland, March 10, 2022 (GLOBE NEWSWIRE) — AgEagle Aerial Systems Inc. (NYSE American: UAVS) (“AgEagle” or the “Company”), an industry-leading provider of full-stack drone, sensor and software solutions, today announced that senseFly, an AgEagle subsidiary, is one of the first eleven vendors to complete the required testing, evaluations and demonstration process to be designated a Blue UAS under the Defense Innovation Unit’s Blue sUAS 2.0. As a result, the NDAA-compliant eBee TAC Unmanned Aerial System (UAS), pioneered by senseFly, has been approved by the...

TORONTO, March 10, 2022 (GLOBE NEWSWIRE) — CF Energy Corp. (TSX-V:CFY) (“CF Energy” or the “Company”; together with its subsidiaries, the “Group”), a leading new energy service provider in the People’s Republic of China (the “PRC” or “China”), is pleased to announce that Zhuhai Xiangzhou District People’s Court in Guangzhou, the PRC (the “Court”) has issued a civil ruling which rejected the plaintiff, Mrs. He Mingfei’s lawsuit against CF Energy’s Chair and CEO, Ann Lin and two other of her family members regarding the pre-arranged inheritance plan initiated by the Company’s late founder, Chairman and CEO, Mr. Lin Huajun. The Court ruling was made in accordance with Chinese civil law and Supreme People’s Court’s regulations. About CF Energy Corp. (Previously known as: Changfeng Energy Inc.)CF Energy Corp. is a Canadian public company...

WORCHESTER, Mass., March 10, 2022 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that Manuel Litchman, M.D., President and Chief Executive Officer, will participate in three virtual investor conferences in March 2022. Details of the events are as follows:Oppenheimer’s 32nd Annual Virtual Healthcare Conference: The company will participate in a fireside chat on Tuesday, March 15, 2022, at 4:00 p.m. ET and will participate in one-on-one meetings during the conference. A webcast of the company’s fireside chat will be available on the News & Events page of the Investor Relations section...

NEW YORK, March 10, 2022 (GLOBE NEWSWIRE) — Transcript for Fireside chat between Peter Oey, Chief Financial Officer at Grab and Michael Grimes, Managing Director and Head of Global Technology Investment Banking at Morgan StanleyMichael Grimes:   Michael Grimes from Michael Stanley. Please visit the Morgan Stanley Research Disclosure website for legal disclosures regarding everything relating to that as well as Grab’s filings for a discussion of the risk factors. And obviously anything that they share today is covered under that documentation and is only true as it is made. We have with us here today, Peter Oey, the CFO of Grab. Thank you so much for joining us.     Peter Oey:   Thank you, Michael. Thank you for the folks who are listening in today.     Michael Grimes:   For those of who — most of you...

FREDERICK, Md., March 10, 2022 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company that specializes in disinfection and decontamination through the utilization of its premier Binary Ionization Technology (BIT) platform, today announced that it has fulfilled an urgent shipment of multiple SteraPak units to its local distributor in Hong Kong, Tomimist Hong Kong. The units were deployed by a well-known real-estate conglomerate in Hong Kong for use in shopping malls, commercial and residential buildings, and numerous other business premises to effectively combat the massive outbreak of COVID-19 Omicron variant infections in the city. Dr. Halden Shane, CEO of TOMI Environmental Solutions, commented, “We are pleased to provide our SteraPak units to assist in the mitigation of the recent COVID-19...

Fort Lee, NJ, March 10, 2022 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT), (“Nuvectis” or the “Company”) a biopharmaceutical company focused on the development of precision medicines for serious conditions of unmet medical need in oncology, today announced that an abstract related to NXP800 has been selected for an oral presentation and an abstract related to NXP900 has been selected for a poster presentation at the upcoming 2022 American Association for Cancer Research Meeting (2022 AACR), taking place from April 8th to April 13th in New Orleans. Presentation details are below: Oral PresentationTitle NXP800: A first-in-class orally active, small-molecule HSF1 pathway inhibitorPresenter Prof. Paul WorkmanSession New Drugs on the Horizon: Part 2Date and Time April 10, 2022, 3:00 PM – 4:30 PM...

MONTREAL, March 10, 2022 (GLOBE NEWSWIRE) — Dorel Industries, Inc. (TSX: DII.B, DII.A)CONFERENCE CALL:OPEN TO: Analysts, investors and all interested parties   DATE: Friday, March 11, 2022   TIME: 11:00 AM Eastern Time   CALL: 1-888-440-3307THE PRESS RELEASE WILL BE PUBLISHED THE DAY PRIOR (MARCH 10) AFTER MARKETS CLOSE, THROUGH GLOBENEWSWIRE. Please dial in 15 minutes before the conference begins. If you are unable to call in at this time, you may access a recording of the meeting by calling 1-800-770-2030 and entering the passcode 4231183 on your phone. This recording will be available on Friday, March 11, 2022 as of 2:00 PM until 11:59 PM on Friday, March 18, 2022. MEDIA WISHING TO QUOTE AN ANALYST SHOULD CONTACT THE ANALYST PERSONALLY FOR PERMISSION. Note TO FIRST-TIME ANALYSTS: Please contact Saint...